| About us | Services | Products | News | Careers | Contact us |
|
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
|
MedKoo's Collection:
New anticancer agents under worldwide clinical trials
(last update: November 30, 2011)
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
201830 || 2-methoxyestradiol (angiogenesis inhibitor) 200880 || 4-demethylpenclomedine(also see: DMPEN) (alkylation agent) 201804 || AB1010 (also see: Masitinib) (tyrosine kinase inhibitor) 202170 || Abexinostat(also see: PCI-24781; CRA-024781) (HDAC inhibitor) 204110 || ABI-008 (nab-docetaxel) 204120 || ABI-009 (nab-rapamycin) 204130 || ABI-101 (nab-17AAG) 100011 || Abiraterone (androgen biosynthesis inhibitor) 200030 || Abiraterone acetate (androgen biosynthesis inhibitor) 202852 || ABR-215050 (also see: Tasquinimod) (angiogenic inhibitor) 201970 || ABT-263 (also see: Novitoclax) (Bcl-2 Inhibitor) 204140 || ABT-348 (temporally not available) 200044 || ABT-737 (BCL-2 inhibitor) 204150 || ABT-806 (anti-EGFR monoclonal antibody ) 200051 || ABT-828 (a biologic compound that blocks angiogenesis of cancer cells) 203115 || ABT-888 (also see: Veliparib) (PARP inhibitor) 200072 || AC220 (also see: Quizartinib) (FLT3 inhibitor) 200078 || AC480 (also see: BMS-599626) (HER inhibitor) 204160 || ACE-041 (an investigational protein therapeutic that inhibits angiogenesis) 204170 || Acolbifene 201823 || Acyline (also see: MER104) 200080 || Aderbasib (also see: INCB7839) 204190 || ADI-PEG20 (arginine deiminase (ADI) formulated with polyethylene glycol) 202042 || ADW742 (also see: NVP-ADW742) 204200 || AE-37 (Vaccine) 200100 || AEE788 (EGFR, ErbB2, KDR, and Flt-1 inhibitor) 201475 || AEG-40826 (also see: HGS-1029) 202043 || AEW541 (also see: NVP-AEW541) 204220 || AEZS-108 (also see: AN-152) 200115 || AEZS-112 (also see: ZEN012) 200500 || Afatinib (also see: BIBW-2992 ) (EGFR inhibitor) 204230 || AFM-13 (a bispecific, tetravalent human antibody for Hodgkin Lymphoma.) 204250 || AG-013 (Trefoil Factor) 200124 || AG-14699 (also see: Rucaparib, PF-01367338) (PARP1 inhibitor) 200121 || AG-490 (EGFR and JAK inhibitor) 200131 || ALB-109564 201931 || Alisertib (also see: MLN-8237) (Aurora A kinase inhibitor) 204270 || ALN-VSP (an RNAi therapeutic for the treatment of liver cancers ) 200160 || ALS357 ( also see: Betulinic acid) 204280 || ALT-801 (IL-2 recombinant fusion protein) 200170 || Alvespimycin (Hsp90 inhibitor) 200180 || Alvocidib (also see: Flavopiridol) (CDK inhibitor) 204310 || AMG-319 (PI3 Kinase inhibitor ) 204320 || AMG-337 (c-Met inhibitor) 204330 || AMG-386 (angiopoietin inhibitor, an anti-angiopoietin peptibody) 201934 || AMG-706 (also see: Motesanib ) (tyrosine kinase inhibitor) 204340 || AMG-780 (anti-angiopoietin antibody ) 204350 || AMG-820 (antibody that targets c-fms and decreases tumor TAM function) 204360 || AMG-888 (antibody that inhibits HER3 oncogenic signaling) 204370 || AMG-900 (inhibitor of Aurora kinases A, B, and C.) 200200 || Amonafide dihydrohloride 200210 || Amonafide malate (also see: AS-1413) 200720 || Amsilarotene (also see: TAC-101) 201950 || Amuvatinib (also see: MP-470) 204220 || AN-152 (also see: AEZS-108) 200252 || AN-2728 (PDE4 inhibitor) 200230 || Anamorelin hydrochloride 205475 || ANG-1005 (also see: GRN-1005) 204380 || ANX-514 (docetaxel new formulation) 200255 || ANZ-207 (cancer vaccine) 202320 || AP-24534 (also see: Ponatinib) (tyrosine kinase inhibitor) 200135 || Apatinib (VEGFR inhibitor) 200140 || Apaziquone (bioreductive prodrug, hypoxia toxic agent) 200150 || Aplidine (also see: Plitidepsin) 205484 || APN01 (also See: GSK-2586881) 200270 || APO-866 (also See: FK866) (NAMPT inhibitor) 200272 || AR-12 (also see: OSU-03012) 200274 || AR-67(also see: Silatecan , also see: DB-67) 202964 || ARC-100 ( also see: TPI-287) 204420 || ARN-509 (androgen receptor antagonist) 200281 || ARQ-092 (AKT inhibitor) 200283 || ARQ-197 (also see: Tivantinib) (c-Met inhibitor) 200284 || ARQ-501 (also see: R1668, beta-lapachone) 204440 || ARQ-736 (BRAF Inhibitor) 205531 || ARRY-162 (also see: MEK-162) (MEK1/2 inhibitor) 200290 || ARRY-300 (MEK inhibitor) 205660 || ARRY-543 ( also see: Varlitinib) 200313 || ARRY-704 (also see: AZD-8330 ) 205633 || ARX-02 (also see: Sufentanil) 200310 || Arzoxifene 200210 || AS-1413 (also see: Amonafide malate) 200297 || AS-703026 (MEK ½ inhibitor) 202422 || AS703569(also see: R763 ) 200314 || AT-101(also see: Gossypol acetic acid) 200322 || AT-9283 (multikinase inhibitor) 200330 || Atamestane 200370 || Atrasentan 200371 || AUY-922 (also see: NVP-AUY922, VER-52296) (Hsp90 inhibitor) 201944 || AV-412 (also see: MP-412) (EGFR/HER2 tyrosine kinase inhibitor) 202955 || AV-951 (also see: Tivozanib) (VEGFR inhibitor) 200380 || AVE8062(also see: Ombrabulin ) 200390 || AVN-944 (also see: VX-944) (IMPDH inhibitor) 200400 || Axitinib (VEGFR inhibitor) 200410 || AZD-0530 (also see: Saracatinib) (Src and Abl inhibitor) 200420 || AZD-1152 (also see: Barasertib) (Aurora B inhibitor) 200421 || AZD1152-HQPA (Aurora B inhibitor) 204510 || AZD-1480 (JAK2 inhibitor) 200423 || AZD-2281 (also see: Olaparib) (PARP inhibitor) 203200 || AZD-4054 (also see: Zibotentan, ZD4054) 204550 || AZD-4547 (pan-FGFR inhibitor) 205669 || AZD-5363 (PKB/Akt inhibitor) 200426 || AZD-5438 (CDK Inhibitor) 200300 || AZD-6244 (also see: Selumetinib) (MEK 1/2 inhibitor) 200311 || AZD-7762 (checkpoint kinase inhibitor) 200312 || AZD-8055 (mTOR inhibitor) 200313 || AZD-8330 (also see: ARRY-704) 200298 || AZD-8931 (HER1and HER2 inhibitor) 200315 || AZM-475271 200316 || Bafetinib (also see: INNO-406) 200430 || Banoxantrone (hypoxia toxic agent) 200420 || Barasertib (also see: AZD-1152) (Aurora B inhibitor) 202530 || Bardoxolone methyl (also see: RTA402) 200442 || Batimastat 202436 || BAY 73-4506 (also see: Regorafenib) (oral multi-kinase inhibitor) 204610 || BAY 79-4620 (Antibody–drug conjugate) 202431 || BAY86-9766 (also see: RDEA119) (MEK inhibitor) 201802 || BB-2516 (also see: Marimastat) 204630 || BC-819 (a plasmid comprised of the H19 gene regulatory sequences ) 200455 || Beclometasone dipropionate 200460 || Belinostat (HDAC inhibitor) 200284 || beta-lapachone (also see: R1668, ARQ-501) 200160 || Betulinic acid ( also see: ALS357) 204920 || Bevonium methylsulfate (also see CG-201) 200491 || BEZ235 ( also see: NVP-BEZ235) 204790 || Bezielle (also see: BZL-101) 204790 || Bezielle (also see: BZL-101) 202270 || BGC-9331 (also see: Plevitrexed) 209490 || BGC-945 (also see: ONX-0801) 204640 || BGJ-398 (pan FGFR kinase inhibitor) 204650 || BHQ-880 (Antibody) 200493 || BI-2536 (Polo-like kinase 1 inhibitor) 204660 || BI-505 (anti-ICAM-1 monoclonal antibody BI-505 ) 200494 || BI-6727 (also see: Volasertib) (Plk1 inhibitor) 200495 || BI-831266 (Not available temporially) 200496 || BIBF-1120 (also see: Intedanib ) (VEGFR inhibitor) 200500 || BIBW-2992 (also see: Afatinib) (EGFR inhibitor) 204665 || BIIB-015 (DM4-conjugated anti-Cripto monoclonal antibody ) 200505 || BIIB-021 (also see: CNF2024) (HSP90 inhibitor) 204670 || BIIB-022 (a human, nonglycosylated IgG4 monoclonal antibody) 204680 || BIW-8962 (anti-ganglioside GM2 monoclonal antibod) 204690 || BKM-120 (PI3K inhibitor) 202834 || BMS-247615 (also see: TAS-103) 200520 || BMS-275183 202640 || BMS-387032 (also see: SNS-032) 200521 || BMS-536924 200524 || BMS-536924 200078 || BMS-599626 (also see: AC480) (HER inhibitor) 200531 || BMS-641988 200533 || BMS-690514 201275 || BMS-753493(also see: Epofolate ) 200534 || BMS-754807 (IGF-1R inhibitor) 200527 || BMS-777607 (Met tyrosine kinase inhibitor) 200535 || BMS-833923 (also see: XL-139) 204730 || BMS-908662 (also see: XL281) 204740 || BMS-936558 (an anti-programmed death-1 (MDX-1106)) 204750 || BMS-936559 (an anti-programmed death-1) 200540 || BN2629 (also see: SJG-136, SG2000) 200550 || BN83495 (also see: STX64, Irosustat) 201630 || BNP-1350 (also see: Cositecan, Karenitecin ) 200560 || Bosutinib (Abl and Src inhibitor) 200569 || Brivanib (VEGFR2 inhibitor) 200570 || Brivanib alaninate (VEGFR2 inhibitor) 202520 || Brivudin (also see: RP-101) 200582 || BSI-201 (also see: Iniparib) (PARP inhibitor) 204770 || BT-062 (Anti-myeloma monoclonal antibody-DM4 immunoconjugate) 204790 || BZL-101 (also see: Bezielle) 204810 || C31510 (not available) 200800 || CA4P (also see: combretastatinA-4phosphate, Fosbretabulin) 200585 || Cabazitaxel (also see: XRP-6258) 200595 || Cabozantinib (also see: XL-184) (VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor) 200586 || CAL-101 (PI3K inhibitor) 204820 || CALAA-01 (siRNA-based cancer drug) 200590 || Calcitriol 200600 || Canertinib 201453 || Capesaris (Also see: GTX-758) 204830 || Carboxyamidotriazole orotate (CTO) 200630 || Carfilzomib (proteasome inhibitor) 202600 || CB1089 (also see: Seocalcitol) 204840 || CB-1400 (Not Available) 202020 || CB-3304 (also see: Noscapine) 202385 || CBLC102 (also see: Quinacrine; Mepacrine) 204880 || CDX-011 (antibody-drug conjugate). 204890 || CDX-1401 (fusion protein / antibody ) 200690 || Cediranib dihydrochloride 200694 || Celastrol (HSP90 inhibitor) 200721 || Cerovive (also see: NXY-059) 200730 || Cevipabulin (antimicrotubule agent) 204920 || CG-201 (also see Bevonium methylsulfate) 200750 || CGC-11047 (also see: PG-11047) 200752 || CGS-21680 (adenosine A2A receptor agonist) 200755 || Chelerythrine chloride 204930 || Chidamide (also see: CS055; HBI-8000) 200760 || CHIR258 (also see: TKI-258, Dovitinib) 200770 || CHIR-265 (also see: RAF-265) 200774 || CHIR-99021 200776 || CHS-828 (NAD inhibitor) 200771 || CI-1040 (also see: PD184352) 205612 || CKI27 (also see: RG7304) 204950 || CLT-008 (human myeloid progenitor cells) 200505 || CNF2024 (also see: BIIB-021) (HSP90 inhibitor) 204960 || CNTO-95 (a fully human monoclonal IgG1 antibody) 204970 || CO-101 (also see: CP-4126) (antimetabolite agent) 200800 || CombretastatinA-4phosphate(also see: Fosbretabulin , CA4P) 200793 || Cordycepin (also see: OVI-123) 201630 || Cositecan (also see: BNP-1350, Karenitecin ). 204970 || CP-4126 (also see: CO-101) (antimetabolite agent) 205020 || CP-868596 (also see: Crenolanib ) 205260 || CPP-1X (also see: Eflornithine) 202170 || CRA-024781(also see: Abexinostat; PCI-24781) (HDAC inhibitor) 205020 || Crenolanib (also see: CP-868596) 202222 || Crizotinib (also see: PF-2341066) (tyrosine kinase inhibitor) 200831 || Crolibulin (also see: EPC2407) 205050 || CRS-100 [a live-attenuated strain of Listeria monocytogenes (Lm)] 205060 || CRS-207 [a weakened (attenuated) form of Listeria monocytogenes] 204930 || CS055 (also see Chidamide; HBI-8000) 205250 || CS-7017 (also see: Efatutazone, inolitazone) 205070 || CST-101 (the native NK-92 cell-line) 205080 || CT-011 (a humanized monoclonal antibody (mAb) that modulates the immune response and inhibits tumor growth and the spread of metastases.) 200841 || CUDC-101 (HDAC, EGFR and HER2 inhibitor) 205090 || Custiren (also see: TV-1001, also see: OCX-011) [a mixed-backbone antisense oligodeoxynucleotide with chemosensitizing properties.] 205110 || CV9103 (mRNA-derived prostate cancer vaccine) 200842 || CVT-6883 (A2B adenosine antagonist) 202380 || CX-3543 (also see: Quarfloxin) 200844 || CYC-116 (Aurora kinase/VEGFR2 inhibitor) 205130 || CYT-107 (Interleukin-7) 200786 || CYT-387 (JAK inhibitor) 205140 || CYT-6091 (a nanotherapeutic manufactured by covalently linking tumor necrosis factor-a (TNF) onto the surface of 30 nm particles of pegylated colloidal gold) 205479 || Dabrafenib (Also see: GSK-2118436) (B-RAF inhibitor) 200845 || Dacinostat (also see: NVP-LAQ824) 205576 || Dacomitinib (also see: PF-00299804) (EGFR inhibitor) 200846 || Danusertib 200850 || Darinaparsin (also see: ZIO-101) 200274 || DB-67 (also see: AR-67, also see: Silatecan) 200860 || Deforolimus (also see: Ridaforolimus) 200890 || Denibulin (also see: MN-029) 201000 || Dexmethylphenidate hydrochloride 202572 || Dinaciclib (also see: SCH-727965, PS-095760) (CDK inhibitor) 202881 || DJ-927 (also see: Tesetaxel ) 200880 || DMPEN(also see: 4-demethylpenclomedine) (alkylation agent) 201050 || DMXAA(also see: Vadimezan ) 201060 || Docosahexaenoic acid 201065 || Dofequidar 200760 || Dovitinib (also see: TKI-258, CHIR258) 201080 || E7080 (also see: lenvatinib) 205160 || E7272 (also see : ONTAK or denileukin diftitox) 201290 || E7389 (also see: Eribulin mesylate ) 205240 || ECC-33 (also see: RG7686) [monoclonal antibody] 201150 || Edatrexate 201160 || Edotecarin 205250 || Efatutazone (also see: CS-7017, inolitazone) 205260 || Eflornithine (also see: CPP-1X) 205270 || EGEN-001 [non-viral vector consisting of a plasmid DNA encoding the human gene for interleukin 12 (IL-12)] 205280 || EGEN-002 [not available] 202190 || EKB569 (also see: Pelitinib) (pan-ErbB tyrosine kinase inhibitor ) 201195 || Elacytarabine (antimetabolite agent) 201200 || Elagolix (also see: NBI-56418) 201210 || Elesclomol (HSP-90 Inhibitor) 202300 || Elisidepsin (also see: PM-02734) 205492 || EMD1201081 (also see: IMO-2055) 201245 || EMD-1214063 (c-Met inhibitor) 201250 || Eniluracil 201264 || ENMD-2076 (Aurora kinase inhibitor) 201266 || Entinostat (also see: MS-275, SNDX-275) (HDAC inhibitor) 201270 || Enzastaurin (also see: LY317615) 205340 || EP-100 [an LHRH receptor-targeting
ligand conjugated to a novel 200831 || EPC2407 (also see: Crolibulin) 202160 || EPO906 (also see: Patupilone) 201275 || Epofolate (also see: BMS-753493) 201290 || Eribulin mesylate (also see: E7389) 205510 || Erismodegib (also see: LDE225, NVP-LDE225) (Smo antagonist) 205350 || ETBX-011 (an immunotherapeutic to treat colorectal cancer) 201320 || Ethonafide 100335 || Everolimus 201372 || EXEL-2880 (also see: XL888, SK1363089, GSK089, Foretinib ) (MET/VEGFR2 inhibitor) 201360 || Ezatiostat hydrochloride 205380 || EZN-2208 (Pegylated SN-38) 205410 || EZN-2968 [a novel hypoxia-inducible factor-1a messenger ribonucleic acid antagonist (IC50 ~1-5 nM)] 205420 || EZN-3042 [a locked nucleic acid antisense oligonucleotide]. 205440 || FG-3019 (anti-CTGF monoclonal antibody) 200270 || FK866 (also See: APO-866) (NAMPT inhibitor) 200180 || Flavopiridol (also see: Alvocidib) (CDK inhibitor) 201372 || Foretinib (also see: XL888, SK1363089, GSK089, EXEL-2880) (MET/VEGFR2 inhibitor) 201390 || Forodesine 200800 || Fosbretabulin (also see: combretastatinA-4phosphate, CA4P) 205588 || FP-1039 (A soluble fusion protein) 205463 || FP-1039 (an FGFR1-Fc fusion protein) 205646 || Galeterone (also see: TOK-001) 202703 || Ganetespib (also see: STA-9090) 205467 || GDC-0068 (AKT inhibitor) 203500 || GDC-0449 (also see: RG3616, Vismodegib) (Hedgehog antagonist) 201395 || GDC-0941 (PI3K inhibitor) 203185 || GDC-0973 (also see: XL518) (MEK inhibitor) 205470 || GDC-0980 (also see: RG7422) ( PI3 kinase/mTOR inhibitor) 205473 || GI-4000 (Targeted Molecular Immunogen) 205474 || GI-6207 (vaccine) 202860 || GMX-1777 (also see: Teglarinad chloride) 200314 || Gossypol acetic acid (also see: AT-101) 205475 || GRN-1005 (also see: ANG-1005) 205489 || GRN-163L (also see: Imetelstat) 205476 || GS-6624 (humanized monoclonal antibody) 205569 || GS7904L (also see: OVI-237, OSI-7904L) 201372 || GSK089 (also see: XL888, SK1363089, Foretinib, EXEL-2880) (MET/VEGFR2 inhibitor) 201456 || GSK1070916 201458 || GSK-1120212 (aslo see: Trametinib, JTP-74057) (MEK 1/2 inhibitor) 205478 || GSK-2110183 (Akt inhibitor) 205479 || GSK-2118436 (Also see: Dabrafenib) (B-RAF inhibitor) 205480 || GSK-2126458 (PI3K inhibitor) 205481 || GSK-2141795 (Akt inhibitor) 205484 || GSK-2586881 (also See: APN01) 205667 || GSK-461364 (PLK Inhibitor) 205670 || GSK-690693 (pan-Akt kinase inhibitor) 201453 || GTX-758 (Also see: Capesaris) 202161 || GW786034 (also see: Pazopanib Hydrochloride) (tyrosine kinase inhibitor ) 202050 || GX15-070 (also see: Obatoclax ) 204930 || HBI-8000 (also see: CS055; Chidamide) 201466 || Hesperadin 201475 || HGS-1029 (also see: AEG-40826) 201470 || HKI272 (also see: Neratinib) (HER2 and EGFR inhibitor) 202075 || Homoharringtonine(also see: Omacetaxine mepesuccinate ) 201491 || HRC-302 (Hemosol cell therapy) 205488 || Iboctadekin (immunostimulatory cytokine ) 201684 || Ibutamoren 205489 || Imetelstat (also see: GRN-163L) 205490 || IMGN-388 (Targeted Antibody Payload, TAP) 205491 || IMGN-901 (lorvotuzumab mertansine) 205492 || IMO-2055 (also see: EMD1201081) 201512 || INCB-18424 (also see: Ruxolitinib) (JAK1 inhibitor) 205493 || INCB-24360 205494 || INCB-28060 200080 || INCB7839 (also see: Aderbasib) 201530 || Indibulin (also see: ZIO-301) 201545 || Ingenol Mebutate (also see: PEP005) 200582 || Iniparib (also see: BSI-201) (PARP inhibitor) 205495 || INK-128 (mTOR inhibitor) 201550 || INNO-206 (DNA intercalating agent) 200316 || INNO-406 (also see: Bafetinib) 205250 || Inolitazone(also see: CS-7017, Efatutazone ) 200496 || Intedanib (also see: BIBF-1120) (VEGFR inhibitor) 201570 || Iobenguane 205496 || Ioflubenzamide I-131 (also see: MIP-1145) 205497 || IPH-2101 (human anti-NK-cell inhibitory receptor mAb) 202450 || IPI504 (also see: Retaspimycin) (HSP90 inhibitor) 200550 || Irosustat (also see: STX64, BN83495) 205499 || ISF-35 (vaccine) 202000 || isocoumarin (also see: NM-3) 201614 || JNJ-26854165 (also see: Serdemetan) 201615 || JNJ-38877605 (tyrosine kinase inhibitor) 201458 || JTP-74057 (aslo see: Trametinib, GSK-1120212) (MEK 1/2 inhibitor) 205502 || JX-594 (thymidine kinase-deleted vaccinia-hGM-CSF) 205503 || JX-929 (A highly tumor-selective vaccinia virus ) 201630 || Karenitecin (also see: Cositecan, BNP-1350). 205504 || KB-004 (Humaneered™ monoclonal antibody) 205505 || KHK-2866 (Anti-HB-EGF Antibody) 201650 || KOS-1584 (also see: R1645) 203060 || KRX-0601(also see UCN-01) 205506 || KW-2478 (Hsp90 inhibitor) 201705 || Laromustine(also see: VNP40101M) 201710 || Larotaxel (also see: XRP9881) 202151 || LBH589 (also see: Panobinostat; NVP-LBH589) (HDAC inhibitor) 205510 || LDE225 (also see: Erismodegib, NVP-LDE225) (Smo antagonist) 205512 || LE-DT (Liposome Encapsulated Docetaxel) 201724 || Lemuteporfin (also see: QLT-0074) 201080 || lenvatinib (also see: E7080) 205514 || LEP-ETU (liposomal paclitaxel, also see: PNU-93914) 100542 || Levoleucovorin Calcium 200060 || Linifanib ( also see: ABT869) 202096 || Linsitnib (also see: OSI-906) (IGF-1R inhibitor) 205521 || Litronesib (aslo see: LY2523355) 201760 || Lonafarnib 201780 || Lucanthone 205520 || LY2157299 (type I receptor TGF-beta kinase antagonist) 205519 || LY2181308 (antisense oligonucleotide) 201792 || LY2334737 (antimetabolite agent) 205521 || LY2523355 (aslo see: Litronesib) 205524 || LY2624587 (not available) 205525 || LY2780301 (AKT inhibitor) 205528 || LY2875358 (anti-c-MET monoclonal antibody) 201795 || LY294002 (PI3K inhibitor) 201270 || LY317615 (also see: Enzastaurin) 202851 || LY573636 (also see: Tasisulam) 201802 || Marimastat (also see: BB-2516) 202031 || Marizomib (also see: NPI-0052) (proteasome inhibitor) 201804 || Masitinib (also see: AB1010) (tyrosine kinase inhibitor) 205531 || MEK-162 (also see: ARRY-162) (MEK1/2 inhibitor) 202385 || Mepacrine (also see: Quinacrine; CBLC102) 201823 || MER104 (also see: Acyline) 203160 || Mesupron (also see: WX-671) 205650 || Methoxyamine (also see: TRC102) 205533 || Methyl aminolevulinate 205671 || MG-516 (multi-targeted kinase inhibitor) 201933 || MGCD-0103 (also see: Mocetinostat) (HDAC inhibitor) 201841 || MGCD-265 (multitargeted tyrosine kinase inhibitor) 201850 || Midostaurin (also see: PKC412) 205535 || MINT-1526A (An anti-murine integrin α5β1 antibody) 205496 || MIP-1145 (also see: Ioflubenzamide I-131) 201900 || MK-0457 (also see Tozasertib; VX-680) (Aurora inhibitor) 202062 || MK-0822 (also see: Odanacatib) (protease inhibitor) 201912 || MK-1775 (WEE inhibitor) 201913 || MK-2206 (Akt inhibitor) 201915 || MK-4101 (not available) 201916 || MK-4827 (PARP inhibitor) 201917 || MK-5108 (also see: VX-689) 205539 || MKC1106-PP (immunotherapy) 202790 || MLN0518 (also see: Tandutinib) (tyrosine kinase inhibitor) 201930 || MLN-8054 (aurora kinase inhibitor) 201931 || MLN-8237 (also see: Alisertib) (Aurora A kinase inhibitor) 205541 || MLN-9708 (also see: Ixazomib) 205542 || MM-111 (a bispecific antibody). 205720 || MM-302 (doxorubicin nanotherapy) 205543 || MM-398 (irinotecan nanotherapy) 200890 || MN-029 (also see: Denibulin) 201933 || Mocetinostat (also see: MGCD-0103) (HDAC inhibitor) 201934 || Motesanib (also see: AMG-706) (tyrosine kinase inhibitor) 201940 || Motexafin gadolinium 201944 || MP-412 (also see: AV-412) (EGFR/HER2 tyrosine kinase inhibitor) 201950 || MP-470 (also see: Amuvatinib) 201960 || MPC-6827 (also see: Verubulin) 201266 || MS-275 (also see: Entinostat, SNDX-275) (HDAC inhibitor) 205546 || MT-110 (a Bispecific T cell Engager (BiTE)® antibody) 205547 || Muparfostat (also see: PI88, heparin sulfate) 205548 || MVA-5T4 (attenuated modified Vaccinia Ankara virus) 205549 || Nabiximols 201955 || NB-1011 (also see: Thymectacin). 201200 || NBI-56418 (also see: Elagolix) 203111 || NC-2300 (also see: VEL-0230) 201470 || Neratinib (also see: HKI272) (HER2 and EGFR inhibitor) 201985 || Netupitant 201990 || Nilotinib (Bcr-Abl inhibitor) 202000 || NM-3 (also see: isocoumarin) 202010 || Nolatrexed 202020 || Noscapine (also see CB-3304) 201970 || Novitoclax (also see: ABT-263) (Bcl-2 Inhibitor) 202031 || NPI-0052 (also see: Marizomib) (proteasome inhibitor) 202040 || NPI-2358 (also see: Plinabulin) 205557 || NTX-10 (vaccine) 205558 || NV-1020 (oncolytic herpes simplex virus type 1) 202042 || NVP-ADW742 (also see: ADW742) 202043 || NVP-AEW541 (also see: AEW541) 200371 || NVP-AUY922 (also see: AUY-922, VER-52296) (Hsp90 inhibitor) 200491 || NVP-BEZ235 ( also see: BEZ235) 200845 || NVP-LAQ824 (also see: Dacinostat) 202151 || NVP-LBH589 (also see: Panobinostat; LBH589) (HDAC inhibitor) 205510 || NVP-LDE225 (also see: LDE225, Erismodegib) (Smo antagonist) 202045 || NVP-TAE684 (also see: TAE684) (ALK Inhibitor) 200721 || NXY-059 (also see: Cerovive) 202050 || Obatoclax ( also see: GX15-070) (BCL-2 Inhibitor) 205559 || Oblimersen (bcl-2 antisense oligodeoxynucleotide G3139) 205560 || OBP-301 (Telomerase-Specific Replication-Competent Adenovirus) 202087 || OC144-093 (also see: ONT-093) 205090 || OCX-011 (also see: Custiren, also see: TV-1001) [a mixed-backbone antisense oligodeoxynucleotide with chemosensitizing properties.] 202062 || Odanacatib (also see: MK-0822) (protease inhibitor) 202064 || Oglufanide 205561 || OGX-427 (Hsp27 antisense oligonucleotide ) 200423 || Olaparib (also see: AZD-2281) (PARP inhibitor) 202070 || Oleandrin (also see: PBI-05204) 202075 || Omacetaxine mepesuccinate (also see: Homoharringtonine) 200380 || Ombrabulin (also see: AVE8062) 202080 || ON-01910 (also see: Rigosertib) 202087 || ONT-093 (also see: OC144-093) 205625 || ONX 0805 (also see: SB1578) 209490 || ONX-0801 (also see: BGC-945) 200724 || Orteronel (also see: TAK-700) 202094 || OSI-027 (mTOR inhibitor) 205569 || OSI-7904L(also see: GS7904L, OVI-237 ) 202096 || OSI-906 (also see: Linsitnib) (IGF-1R inhibitor) 202103 || Ostarine (also see: MK-2866, GTX-024) 202103 || MK-2866 (also see: Ostarine, GTX-024) 202103 || GTX-024 (also see: MK-2866, Ostarine) 200272 || OSU-03012 (also see: AR-12) 202101 || OVI123 (also see: Cordycepin) 200793 || OVI-123 (also see: Cordycepin) 205569 || OVI-237 (also see: GS7904L, OSI-7904L) 202110 || Ozarelix (also see: SPI-153) 205571 || PA-799 (not available) 202571 || Pacritinib (also see: SB1518) 202185 || Padoporfin (also see: Tookad) 202130 || Palifosfamide (also see: ZIO-201) 202133 || Palomid 529 (PI3K inhibitor; Akt inhibitor; mTOR inhibitor) 202151 || Panobinostat (also see: NVP-LBH589; LBH589) (HDAC inhibitor) 205572 || Pasireotide (also see: SOM-230) 202160 || Patupilone (also see: EPO906) 202161 || Pazopanib Hydrochloride (also see: GW786034) (tyrosine kinase inhibitor ) 202070 || PBI-05204 (also see: oleandrin) 202170 || PCI-24781(also see: Abexinostat; CRA-024781) (HDAC inhibitor) 202171 || PCI-32765 (BTK inhibitor) 202172 || PD-0325901 (MEK inhibitor) 202173 || PD-0332991 (CDK Inhibitor) 202174 || PD-153035 (EGFR inhibitor) 200771 || PD184352 (also see: CI-1040) 202190 || Pelitinib (also see: EKB569) (pan-ErbB tyrosine kinase inhibitor) 202200 || Pelitrexol 201545 || PEP-005 (also see: Ingenol Mebutate) 202220 || Perifosine (AKT Inhibitor) 205576 || PF-00299804 (also see: Dacomitinib) (EGFR inhibitor) 202228 || PF-00562271 (also see: PF-562271) 200124 || PF-01367338 (Also see: Rucaparib, AG-014699) (PARP1 inhibitor) 205580 || PF-03446962 (anti-ALK-1 monoclonal antibody) 205581 || PF-03758309 (PAK4 inhibitor) 205584 || PF-04605412 (anti-A5B1 integrin monoclonal antibody ) 202226 || PF-04691502 (PI3K/mTOR inhibitor) 205586 || PF-04856884 (also see: CVX-060) [the fusion of two Ang2 sequestering peptides] 202255 || PF-05212384 (also see: PKI-587) 202222 || PF-2341066 (also see: Crizotinib) (tyrosine kinase inhibitor) 202223 || PF-299804 (not available) 202221 || PF-4217903 ( MET tyrosine kinase inhibitor) 202651 || PF-4929113 (also see: SNX-5422) 202228 || PF-562271 (also see: PF-00562271) 200750 || PG-11047 (also see: CGC-11047) 202231 || PHA-665752 202233 || PHA-848125 202242 || Photochlor 202230 || Picoplatin 202238 || PIK-75 (PI3K inhibitor) 202250 || Pixantrone 201850 || PKC412(also see: Midostaurin ) 202255 || PKI-587 (also see: PF-05212384) 202260 || Plerixafor 202270 || Plevitrexed (also see: BGC-9331) 202040 || Plinabulin (also see: NPI-2358) 200150 || Plitidepsin (also see: Aplidine) 205611 || PLX3603 (also see: RG-7256, RO5212054) 202271 || PLX4032 (also see: RG7204, Vemurafenib, RO5185426) (B-Raf inhibitor) 202272 || PLX-4720 (B-Raf inhibitor) 202300 || PM-02734 (also see: Elisidepsin) 205596 || PNT-2258 (an oligonucleotide therapeutic encapsulated within a SMARTICLES formulation). 205514 || PNU-93914 (liposomal paclitaxel, also see: LEP-ETU) 202320 || Ponatinib (also see: AP-24534) (tyrosine kinase inhibitor) 202324 || PP242 (mTOR inhibitor) 205626 || Pracinostat (also see: SB939) 202334 || PRLX-93936 205597 || PRT-062607 205598 || PRX-302 (protein drug) 202572 || PS-095760 (also see: SCH-727965, Dinaciclib) (CDK inhibitor) 205599 || PTC-299 (VEGF inhibitor) 205601 || PTI-188 (a radiolabeled murine anti-melanin antibody) 202350 || PX-478 (HIF-1alpha inhibitor) 202370 || Pyroxamide 205603 || QBI-139 (protein drug) 201724 || QLT-0074 (also see: Lemuteporfin) 202380 || Quarfloxin (also see: CX-3543) 202385 || Quinacrine(also see: Mepacrine ; CBLC102) 202390 || Quinagolide hydrochloride 200072 || Quizartinib (also see: AC220) (FLT3 inhibitor) 202391 || R1530 (Mitosis-angiogenesis inhibitor) 201650 || R1645 (also see: KOS-1584) 200284 || R1668 (also see: ARQ-501, beta-lapachone) 202412 || R4733 (also see: RO4929097) 202421 || R7112 (also see: RG7112, RO5045337) 202422 || R763 (also see: AS703569) 200770 || RAF-265 (also see: CHIR-265) 202431 || RDEA119 (also see: BAY86-9766) (MEK inhibitor) 202436 || Regorafenib (also see: BAY 73-4506) (oral multi-kinase inhibitor) 202701 || Resveratrol(also see: RM1812 , SRT-501) 202450 || Retaspimycin (also see: IPI504) (HSP90 inhibitor) 203500 || RG3616 (also see: Vismodegib , GDC-0449) (Hedgehog antagonist) 202421 || RG7112(also see: R7112 , RO5045337) 202271 || RG7204 (also see: PLX4032, Vemurafenib, RO5185426) (B-Raf inhibitor) 205611 || RG-7256 (also see: PLX3603, RO5212054) 205612 || RG7304 (also see: CKI27) 205613 || RG-7347 (MNRP1685, R7347, Anti-NRP1) 205470 || RG7422 (also see: GDC-0980) (PI3 kinase/mTOR inhibitor) 205615 || RG7593 (anti-CD22-MCC-MMAE) 205616 || RG7594 (antibody drug) 205240 || RG7686 (also see: ECC-33) [monoclonal antibody] 200860 || Ridaforolimus (also see: Deforolimus) 202080 || Rigosertib(also see: ON-01910 ) 205617 || Rindopepimut (immunotherapy, vaccine) 202701 || RM1812 (also see: resveratrol, SRT-501) 202412 || RO4929097 (also see: R4733) 202421 || RO5045337 (also see: RG7112, R7112) 202271 || RO5185426 (also see: RG7204, Vemurafenib, PLX4032) (B-Raf inhibitor) 205611 || RO5212054 (also see: PLX3603, RG-7256) 202470 || Rolapitant 202500 || Roquinimex 202520 || RP-101 (also see: Brivudin) 202530 || RTA402 (also see: Bardoxolone methyl) 200124 || Rucaparib (Also see: PF-01367338, AG-14699) (PARP1 inhibitor) 201512 || Ruxolitinib (also see: INCB-18424) (JAK1 inhibitor) 205618 || RX-0201 (Akt antisense oligonucleotide) 203210 || Sagopilone (also see: ZK epothilone) 203181 || SAR-245408 (also see: XL147) (PI3K inhibitor) 203187 || SAR-245409 (also see: XL765) (PI3K/mTOR inhibitor) 205620 || SAR256212 (also see: MM-121, human monoclonal antibody) 205622 || SAR307746 (also see: REGN901, anti-ANG2 monoclonal antibody) 205624 || SAR411298 (FAAH inhibitor. Cancer pain) 200410 || Saracatinib (also see: AZD-0530) (Src and Abl inhibitor) 202571 || SB1518 (also see: Pacritinib) 205625 || SB1578 (also see: ONX 0805) 205626 || SB939 (also see: Pracinostat) 202572 || SCH-727965 (also see: Dinaciclib, PS-095760) (CDK inhibitor) 202573 || SCH900776 (Chk1 inhibitor) 205572 || SDM-230 (also see: Pasireotide) 202580 || Seliciclib 200300 || Selumetinib (also see: AZD-6244) (MEK 1/2 inhibitor) 202600 || Seocalcitol (also see: CB1089) 201614 || Serdemetan (also see: JNJ-26854165) 205627 || SF1 (also see: Sonoflora 1) 200540 || SG2000 (also see: BN2629, SJG-136) 205710 || SGI-1776 (pan-Pim protein kinase inhibitor) 205630 || SGN-75 (anti-CD70 monoclonal antibody) 205715 || SGX-523 (Met Inhibitor) 200274 || Silatecan (also see: AR-67, also see: DB-67) 200540 || SJG-136 (also see: BN2629, SG2000) 201372 || SK1363089 (also see: XL888, Foretinib, GSK089, EXEL-2880) (MET/VEGFR2 inhibitor) 205631 || SL-401 (human IL3 recombinantly conjugated to diphtheria toxin). 201266 || SNDX-275(also see: MS-275, Entinostat ) (HDAC inhibitor) 202640 || SNS-032 (also see: BMS-387032) 202650 || SNS-595 (also see: Voreloxin, Vosaroxin) 202651 || SNX-5422 (also see: PF-4929113) 202660 || Soblidotin 205627 || Sonoflora 1 (also see: SF1) 205632 || Sotatercept (also see: ACE-011, human fusion protein ) 202110 || SPI-153 (also see: Ozarelix) 202690 || Squalamine 205672 || SR13668 (Akt inhibitor) 202701 || SRT-501 (also see: resveratrol, RM1812) 202703 || STA-9090 (also see: Ganetespib) 200550 || STX64 (also see: Irosustat, BN83495) 205633 || Sufentanil (also see: ARX-02) 205634 || SYM-004 (anti-EGFR monoclonal antibody mixture) 200720 || TAC-101 (also see: Amsilarotene) 202045 || TAE684 (also see: NVP-TAE684) (ALK Inhibitor) 200724 || TAK-700 (also see: Orteronel ) 205637 || TAK-701 (anti-HGF monoclonal antibody) 202730 || Talabostat 202740 || Talampanel 202760 || Taltobulin 202790 || Tandutinib (also see: MLN0518) (tyrosine kinase inhibitor) 202950 || Tanespimycin (also see: Telatinib) (Hsp90 inhibitor) 202953 || Tanomastat (matrix metalloprotease inhibitor) 100803 || Tapentadol 202820 || Tariquidar (p-glycoprotein inhibitor) 202834 || TAS-103 (also see: BMS-247615) 202850 || Tasidotin hydrochloride 202851 || Tasisulam (also see: LY573636) 202852 || Tasquinimod (also see: ABR-215050) (angiogenic inhibitor) 202860 || Teglarinad chloride (also see: GMX-1777) 202950 || Telatinib (also see: Tanespimycin) (Hsp90 inhibitor) 202865 || Temoporfin 202880 || Terameprocol (transcriptional inhibitor) 202881 || Tesetaxel (also see: DJ-927) 202892 || TG100-115 (PI3K inhibitor) 202893 || TG101348 ( JAK2 inhibitor) 202895 || TGX-221 (PI3K inhibitor) 205644 || Thiarabine 201955 || Thymectacin (also see: NB-1011). 202921 || Tigapotide 202926 || Timcodar (also see: VX-853) 202930 || Tipifarnib 202940 || Tirapazamine (hypoxia toic agent) 200283 || Tivantinib (also see: ARQ-197) (c-Met inhibitor) 202955 || Tivozanib (also see: AV-951) (VEGFR inhibitor) 200760 || TKI-258 (also see: Dovitinib, CHIR258) 205646 || TOK-001 (also see: Galeterone) 202185 || Tookad (also see: Padoporfin) 100880 || Toremifene 205648 || Tosedostat 201900 || Tozasertib (also see MK-0457; VX-680) (Aurora inhibitor) 202964 || TPI-287 (also see: ARC-100) 201458 || Trametinib (aslo see: GSK-1120212, JTP-74057) (MEK 1/2 inhibitor) 205649 || TRC093 (a humanized IgG1 monoclonal antibody) 205650 || TRC102 (also see: Methoxyamine) 205651 || TRC105 (human chimeric monoclonal antibody ) 205652 || Treosulfan 202980 || Tretazicar 203010 || Triciribine (also see: VQD-002) (Akt inhibitor) 203020 || Trilostane 205654 || TRX-518 (ully humanized IgG1 anti-huGITR Mab) 203031 || TST-88 (also see TST-10088, a recombinant protein prodrug based on a plant-derived toxin called ricin) 203055 || Tubacin (HDAC6 inhibitor) 205090 || TV-1001 (also see: Custiren, also see: OCX-011) [a mixed-backbone antisense oligodeoxynucleotide with chemosensitizing properties.] 205656 || U3-1565 (anti-HBEGF monoclonal antibody) 203060 || UCN-01(also see KRX-0601) 203091 || Ursodeoxycholic acid ( also see: Ursodiol) 203091 || Ursodiol ( also see: Ursodeoxycholic acid) 205658 || V503 (human papillomavirus vaccine) 205659 || V935 (hTERT vaccine) 201050 || Vadimezan (also see: DMXAA) 203100 || Vandetanib (approved in 2011) (VEGFR and EGFR inhibitor) 205660 || Varlitinib ( also see: ARRY-543) 203110 || Vatalanib (VEGFR inhibitor) 203111 || VEL-0230 (also see: NC-2300) 203115 || Veliparib (also see: ABT-888) (PARP inhibitor) 202271 || Vemurafenib (also see: RG7204, PLX4032, RO5185426) (B-Raf inhibitor) 200371 || VER-52296 (also see: NVP-AUY922, AUY-922) (Hsp90 inhibitor) 203120 || Verteporfin (PDT photosensitizer) 201960 || Verubulin (also see: MPC-6827) 203150 || Vinflunine 205661 || Virulizin (A natural biological response modifier (BRM) isolated from bovine reticuloendothelial tissue). 203500 || Vismodegib (also see: RG3616, GDC-0449) (Hedgehog antagonist) 200494 || Volasertib (also see: BI-6727) (Plk1 inhibitor) 202650 || Voreloxin (also see: SNS-595, Vosaroxin) 202650 || Vosaroxin (also see: Voreloxin, SNS-595) 203152 || VP-701 (not available) 203010 || VQD-002 (also see: Triciribine ) (Akt inhibitor) 201900 || VX-680 (also see MK-0457; Tozasertib) (Aurora inhibitor) 201917 || VX-689 (also see: MK-5108) 203162 || VX-702 (p38 MAPK Inhibitor) 203165 || VX-765 (Caspase inhibitor) 202926 || VX-853 (also see: Timcodar) 200390 || VX-944 (also see: AVN-944) (IMPDH inhibitor) 203160 || WX-671 (also see: Mesupron) 203170 || WZ4002 (EGFR inhibitor) 203180 || Xaliproden 205664 || Xen-2174 (conopeptide analog) 200535 || XL-139 (also see: BMS-833923) 203181 || XL147 (also see: SAR-245408) (PI3K inhibitor) 200595 || XL-184 (also see: Cabozantinib) (VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor) 204730 || XL281 (also see: BMS-908662) 203185 || XL518 (also see: GDC-0973) 203186 || XL647 (EGFR and ErbB2 inhibitor) 203187 || XL765 (also see: SAR-245409) (PI3K/mTOR inhibitor) 201372 || XL888 (also see: Foretinib, SK1363089, GSK089, EXEL-2880) (MET/VEGFR2 inhibitor) 200585 || XRP-6258 (also see: Cabazitaxel) 201710 || XRP9881(also see: Larotaxel ) 203190 || YM-155 (Survivin inhibitor) 203200 || ZD4054 (also see: Zibotentan, AZD-4054) 200115 || ZEN012 (also see: AEZS-112) 203200 || Zibotentan (also see: AZD-4054, ZD4054) 200850 || ZIO-101(also see: Darinaparsin ) 202130 || ZIO-201 (also see: Palifosfamide) 201530 || ZIO-301 (also see:Indibulin) 203210 || ZK epothilone (also see: Sagopilone) 203220 || Zosuquidar trihydrochloride 205668 || ZYC-300 (A plasmid DNA) |
Contact MedKoo: Email: sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|
About us | Services | Products | News | Careers | Contact us